United States Biotechnology & Medical Research

Pfenex Inc (PFNX)

Track

The most recent insider trading activity occurred on June 16, 2020, with a planned sale of 770 shares by Chief Business Officer Lucy Patrick K. Prior to this, significant planned sales by the same executive were noted in March 2020 and November 2019. Earlier transactions in 2018 and 2017 involved purchases by other insiders.
Stock chart
Ticker: PFNX Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Lucy Patrick K.
Chief Business Officer
1 sale — total 7,873 USD
Planned sale 16 Jun 2020
Value US$4,875,410.19 | Price 438.92 | Shares 6,891
Planned sale 2 Mar 2020
Value US$3,178,299.62 | Price 290.74 | Shares 44,734
Planned sale 27 Nov 2019
Value US$30,104.40 | Price 10.03 | Shares 3,000
Planned sale 16 Sep 2019
Value US$2,502.50 | Price 10.01 | Shares 250
Planned sale 16 Sep 2019
Value US$18,000.00 | Price 10.00 | Shares 1,800
Planned sale 13 Sep 2019
Value US$39,532.39 | Price 10.01 | Shares 3,950
Planned sale 6 Sep 2019
Value US$48,021.00 | Price 8.00 | Shares 6,000
Buy 11 Sep 2018
Value US$54,890.00 | Price 4.99 | Shares 11,000
Buy 11 Sep 2018
Value US$2,505.00 | Price 5.01 | Shares 500
Buy 11 Sep 2018
Value US$47,880.00 | Price 5.04 | Shares 9,500
Buy 22 Aug 2018
Value US$24,272.50 | Price 4.85 | Shares 5,000
Buy 12 Jun 2017
Value US$45,058.00 | Price 4.51 | Shares 10,000
Sale 16 May 2017
Value US$9,568.80 | Price 4.78 | Shares 2,000
Sale 6 Jan 2017
Value US$931.00 | Price 9.50 | Shares 98
Sale 6 Jan 2017
Value US$2,869.00 | Price 9.50 | Shares 302
Sale 5 Jan 2017
Value US$3,252.86 | Price 9.51 | Shares 342
Sale 5 Jan 2017
Value US$9,977.35 | Price 9.51 | Shares 1,049
Sale 4 Jan 2017
Value US$14,764.86 | Price 9.50 | Shares 1,554
Sale 4 Jan 2017
Value US$45,273.22 | Price 9.50 | Shares 4,765
Sale 29 Dec 2016
Value US$4,989.46 | Price 9.65 | Shares 517
Sale 29 Dec 2016
Value US$15,315.82 | Price 9.65 | Shares 1,587
Sale 28 Dec 2016
Value US$52,240.04 | Price 9.66 | Shares 5,410
Sale 28 Dec 2016
Value US$160,196.36 | Price 9.66 | Shares 16,590
Sale 27 Dec 2016
Value US$64,440.88 | Price 9.67 | Shares 6,664
Sale 27 Dec 2016
Value US$197,616.12 | Price 9.67 | Shares 20,436
Sale 23 Dec 2016
Value US$182,003.90 | Price 9.55 | Shares 19,058
Sale 23 Dec 2016
Value US$558,121.10 | Price 9.55 | Shares 58,442
Sale 22 Dec 2016
Value US$2,634.50 | Price 9.58 | Shares 275
Sale 22 Dec 2016
Value US$8,095.10 | Price 9.58 | Shares 845
Sale 21 Dec 2016
Value US$23,102.44 | Price 9.61 | Shares 2,404
Sale 21 Dec 2016
Value US$70,844.92 | Price 9.61 | Shares 7,372
Sale 21 Nov 2016
Value US$19,736.00 | Price 9.87 | Shares 2,000
Planned sale 15 Nov 2016
Value US$50,207.50 | Price 10.04 | Shares 5,000
Sale 18 Aug 2016
Value US$18,836.00 | Price 9.42 | Shares 2,000
Sale 24 May 2016
Value US$13,043.00 | Price 6.52 | Shares 2,000
Sale 15 Dec 2015
Value US$7,050,000.00 | Price 11.75 | Shares 600,000
Planned sale 1 Dec 2015
Value US$3,112.00 | Price 15.56 | Shares 200
Sale 18 Nov 2015
Value US$28,101.40 | Price 14.05 | Shares 2,000
Planned sale 4 Nov 2015
Value US$3,609.00 | Price 18.05 | Shares 200
Planned sale 3 Sep 2015
Value US$40,960.20 | Price 20.48 | Shares 2,000
Planned sale 1 Sep 2015
Value US$6,534.00 | Price 21.78 | Shares 300
Planned sale 1 Jul 2015
Value US$4,055.00 | Price 20.28 | Shares 200
Sale 29 Apr 2015
Value US$4,822,072.63 | Price 14.57 | Shares 330,959
Sale 29 Apr 2015
Value US$22,974,092.56 | Price 14.57 | Shares 1,576,808
Sale 29 Apr 2015
Value US$4,822,072.63 | Price 14.57 | Shares 330,959
Sale 29 Apr 2015
Value US$22,974,092.56 | Price 14.57 | Shares 1,576,808
Sale 29 Apr 2015
Value US$13,990,026.58 | Price 14.57 | Shares 960,194
Sale 29 Apr 2015
Value US$18,533,608.23 | Price 14.57 | Shares 1,272,039
Planned sale 1 Apr 2015
Value US$6,389.00 | Price 15.97 | Shares 400
Sale 29 Jul 2014
Value US$92,811.52 | Price 0.31 | Shares 299,392
Sale 29 Jul 2014
Value US$25,257.25 | Price 0.31 | Shares 81,475
Sale 29 Jul 2014
Value US$92,811.52 | Price 0.31 | Shares 299,392
Sale 29 Jul 2014
Value US$25,257.25 | Price 0.31 | Shares 81,475
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-06-17 2020-06-16 PlS Planned sale
Lucy Patrick K.

Chief Business Officer

Officer
6,891 -27.4%
438.92
US$4,875,410 		6,891 -27.4% 438.92 US$4,875,410
2020-03-03 2020-03-02 PlS Planned sale
Lucy Patrick K.

Chief Business Officer

Officer
44,734 -15.8%
290.74
US$3,178,300 		44,734 -15.8% 290.74 US$3,178,300
2019-11-27 2019-11-27 PlS Planned sale
Lucy Patrick K.

Chief Business Officer
52,901 -32.5%
411.80
US$3,960,547 		52,901 -32.5% 411.80 US$3,960,547
2019-09-16 2019-09-16 PlS Planned sale
Lucy Patrick K.

Chief Business Officer
250 -0.3%
10.01
US$2,502 		250 -0.3% 10.01 US$2,502
2019-09-16 2019-09-16 PlS Planned sale
Lucy Patrick K.

Chief Business Officer
1,800 -1.9%
10.00
US$18,000 		1,800 -1.9% 10.00 US$18,000
2019-09-16 2019-09-13 PlS Planned sale
Lucy Patrick K.

Chief Business Officer
3,950 -4.0%
10.01
US$39,532 		3,950 -4.0% 10.01 US$39,532
2019-09-10 2019-09-06 PlS Planned sale
Lucy Patrick K.

Chief Business Officer
6,000 -5.7%
8.00
US$48,021 		6,000 -5.7% 8.00 US$48,021
2018-09-13 2018-09-11 B Purchase SCHNEIDER PHILLIP M Non-Executive Director
11,000 +inf%
4.99
US$54,890 		11,000 +inf% 4.99 US$54,890
2018-09-13 2018-09-11 B Purchase Schimmelpennink Evert B.

See Remarks

Executive Director
500 +1.9%
5.01
US$2,505 		500 +1.9% 5.01 US$2,505
2018-09-13 2018-09-11 B Purchase Schimmelpennink Evert B.

See Remarks

Executive Director
9,500 +57.0%
5.04
US$47,880 		9,500 +57.0% 5.04 US$47,880
2018-08-24 2018-08-22 B Purchase Campbell Robin Non-Executive Director
5,000 +inf%
4.85
US$24,272 		5,000 +inf% 4.85 US$24,272
2017-06-12 2017-06-12 B Purchase Grenfell-Gardner Jason
10,000 +inf%
4.51
US$45,058 		10,000 +inf% 4.51 US$45,058
2017-05-17 2017-05-16 S Sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -36.4%
4.78
US$9,569 		2,000 -36.4% 4.78 US$9,569
2017-01-10 2017-01-06 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
98 -0.0%
9.50
US$931 		98 -0.0% 9.50 US$931
2017-01-10 2017-01-06 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
302 -0.0%
9.50
US$2,869 		302 -0.0% 9.50 US$2,869
2017-01-06 2017-01-05 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
342 -0.1%
9.51
US$3,253 		342 -0.1% 9.51 US$3,253
2017-01-06 2017-01-05 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
1,049 -0.1%
9.51
US$9,977 		1,049 -0.1% 9.51 US$9,977
2017-01-06 2017-01-04 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
1,554 -0.3%
9.50
US$14,765 		1,554 -0.3% 9.50 US$14,765
2017-01-06 2017-01-04 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
4,765 -0.3%
9.50
US$45,273 		4,765 -0.3% 9.50 US$45,273
2016-12-30 2016-12-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
517 -0.1%
9.65
US$4,989 		517 -0.1% 9.65 US$4,989
2016-12-30 2016-12-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
1,587 -0.1%
9.65
US$15,316 		1,587 -0.1% 9.65 US$15,316
2016-12-30 2016-12-28 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
5,410 -1.0%
9.66
US$52,240 		5,410 -1.0% 9.66 US$52,240
2016-12-30 2016-12-28 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
16,590 -1.0%
9.66
US$160,196 		16,590 -1.0% 9.66 US$160,196
2016-12-28 2016-12-27 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
6,664 -1.2%
9.67
US$64,441 		6,664 -1.2% 9.67 US$64,441
2016-12-28 2016-12-27 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
20,436 -1.2%
9.67
US$197,616 		20,436 -1.2% 9.67 US$197,616
2016-12-28 2016-12-23 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
19,058 -3.2%
9.55
US$182,004 		19,058 -3.2% 9.55 US$182,004
2016-12-28 2016-12-23 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
58,442 -3.2%
9.55
US$558,121 		58,442 -3.2% 9.55 US$558,121
2016-12-23 2016-12-22 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
275 -0.0%
9.58
US$2,634 		275 -0.0% 9.58 US$2,634
2016-12-23 2016-12-22 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
845 -0.0%
9.58
US$8,095 		845 -0.0% 9.58 US$8,095
2016-12-23 2016-12-21 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
2,404 -0.4%
9.61
US$23,102 		2,404 -0.4% 9.61 US$23,102
2016-12-23 2016-12-21 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
7,372 -0.4%
9.61
US$70,845 		7,372 -0.4% 9.61 US$70,845
2016-11-22 2016-11-21 S Sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -41.7%
9.87
US$19,736 		2,000 -41.7% 9.87 US$19,736
2016-11-15 2016-11-15 PlS Planned sale Lucy Patrick K.

Chief Business Officer

Officer
5,000 -4.7%
10.04
US$50,208 		5,000 -4.7% 10.04 US$50,208
2016-08-18 2016-08-18 S Sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -41.7%
9.42
US$18,836 		2,000 -41.7% 9.42 US$18,836
2016-05-25 2016-05-24 S Sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -48.8%
6.52
US$13,043 		2,000 -48.8% 6.52 US$13,043
2015-12-17 2015-12-15 S Sale DOW CHEMICAL CO /DE/ Large shareholder
600,000 -21.3%
11.75
US$7,050,000 		600,000 -21.3% 11.75 US$7,050,000
2015-12-02 2015-12-01 PlS Planned sale Liang Bertrand C.

Chief Executive Officer

Executive Director
200 -0.0%
15.56
US$3,112 		200 -0.0% 15.56 US$3,112
2015-11-19 2015-11-18 S Sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -58.8%
14.05
US$28,101 		2,000 -58.8% 14.05 US$28,101
2015-11-05 2015-11-04 PlS Planned sale Lucy Patrick K.

Chief Business Officer

Officer
200 -0.2%
18.05
US$3,609 		200 -0.2% 18.05 US$3,609
2015-09-04 2015-09-03 PlS Planned sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -58.8%
20.48
US$40,960 		2,000 -58.8% 20.48 US$40,960
2015-09-02 2015-09-01 PlS Planned sale Liang Bertrand C.

Chief Executive Officer

Executive Director
300 -0.1%
21.78
US$6,534 		300 -0.1% 21.78 US$6,534
2015-07-02 2015-07-01 PlS Planned sale Liang Bertrand C.

Chief Executive Officer

Executive Director
200 -0.0%
20.28
US$4,055 		200 -0.0% 20.28 US$4,055
2015-04-30 2015-04-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
330,959 -35.8%
14.57
US$4,822,073 		330,959 -35.8% 14.57 US$4,822,073
2015-04-30 2015-04-29 S Sale GALE JAMES C Non-Executive Director
330,959 -35.8%
14.57
US$4,822,073 		330,959 -35.8% 14.57 US$4,822,073
2015-04-30 2015-04-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
1,576,808 -46.4%
14.57
US$22,974,093 		1,576,808 -46.4% 14.57 US$22,974,093
2015-04-30 2015-04-29 S Sale GALE JAMES C Non-Executive Director
1,576,808 -46.4%
14.57
US$22,974,093 		1,576,808 -46.4% 14.57 US$22,974,093
2015-04-29 2015-04-29 S Sale DOW CHEMICAL CO /DE/ Large shareholder
960,194 -100.0%
14.57
US$13,990,027 		960,194 -100.0% 14.57 US$13,990,027
2015-04-29 2015-04-29 S Sale DOW CHEMICAL CO /DE/ Large shareholder
1,272,039 -31.1%
14.57
US$18,533,608 		1,272,039 -31.1% 14.57 US$18,533,608
2015-04-02 2015-04-01 PlS Planned sale Liang Bertrand C.

Chief Executive Officer

Executive Director
400 -0.1%
15.97
US$6,389 		400 -0.1% 15.97 US$6,389
2014-07-31 2014-07-29 S Sale GALE JAMES C Non-Executive Director
299,392 -8.1%
0.31
US$92,812 		299,392 -8.1% 0.31 US$92,812
2014-07-31 2014-07-29 S Sale GALE JAMES C Non-Executive Director
81,475 -8.1%
0.31
US$25,257 		81,475 -8.1% 0.31 US$25,257
2014-07-30 2014-07-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
299,392 -8.1%
0.31
US$92,812 		299,392 -8.1% 0.31 US$92,812
2014-07-30 2014-07-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
81,475 -8.1%
0.31
US$25,257 		81,475 -8.1% 0.31 US$25,257
Explore more

More insider trading research around Pfenex Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America